Post by Evotec

We are pleased to highlight Evotec’s presence at this week's 𝟲𝟱° 𝗦𝗶𝗺𝗽𝗼𝘀𝗶𝗼 𝗔𝗙𝗜, “𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮 𝗱𝗲𝗹𝗹𝗮 𝗦𝗮𝗹𝘂𝘁𝗲 𝗻𝗲𝗹 𝘁𝗲𝗺𝗽𝗼 𝗱𝗲𝗹𝗹’𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝘇𝗮 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹𝗲” (“The Health Industry in the Age of Artificial Intelligence”) in Rimini, Italy, where our colleague Michela Gabaldo, VP, Head of ATMP Global Regulatory Affairs, Cell Therapy will present: “𝗙𝗿𝗼𝗺 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝘁𝗼 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲: 𝗛𝗼𝘄 𝗘𝗨 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘀 𝗮𝗿𝗲 𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝘁𝗵𝗲 𝗨𝘀𝗲 𝗼𝗳 𝗔𝗜 𝗶𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 & 𝗔𝗧𝗠𝗣𝘀.” As regulatory frameworks evolve alongside technological innovation, this session reflects the growing importance of understanding how AI is being integrated into biotech and advanced therapies. It also underscores Evotec’s continued engagement in shaping and contributing to key conversations at the intersection of regulatory science and cutting-edge modalities. Looking forward to insightful discussions and connecting with industry peers in this dynamic space. 🔗 𝗙𝗼𝗿 𝗮𝗻𝘆 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗼𝘂𝗻𝗱 𝗘𝘃𝗼𝘁𝗲𝗰'𝘀 𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝗶𝗲𝘀 𝗶𝗻 𝘁𝗵𝗶𝘀 𝘀𝗽𝗮𝗰𝗲, 𝗽𝗹𝗲𝗮𝘀𝗲 𝗴𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵: [email protected] #AFI2026 #ATMP #iPSC